REVIRAL
ReViral is a developer of antiviral drugs designed to help patients and enlarge the antiviral market by developing novel first-in-class compounds. The company's antiviral drugs is a fusion inhibitor of RSV which is a highly potent, novel small molecule and is being developed to treat RSV in patients with severe disease including neonates, enabling patients to be treated who are infected with respiratory syncytial virus (RSV) by developing novel compounds.
REVIRAL
Industry:
Biotechnology Health Care Medical Therapeutics
Founded:
2011-01-01
Address:
Stevenage, Herefordshire, United Kingdom
Country:
United Kingdom
Website Url:
http://www.reviral.co.uk
Total Employee:
11+
Status:
Active
Contact:
44 29 2078 1795
Email Addresses:
[email protected]
Total Funding:
121 M USD
Technology used in webpage:
Viewport Meta IPhone / Mobile Compatible SPF SSL By Default Google Font API Google Analytics LetsEncrypt Apple Mobile Web Clips Icon Google Tag Manager WordPress
Similar Organizations
Rakuten Medical
Rakuten Medical is a Bio-technology Company.
Biotrics Bioimplants
Biotrics Bioimplants is a biotechnology company that develops biomaterials for oral tissue regeneration.
Remix Therapeutics
Remix Therapeutics is a biotechnology company.
Tango Therapeutics
Tango Therapeutics is a biotechnology company that is developing next generation cancer therapies.
Current Advisors List
Current Employees Featured
Founder
Investors List
Andera Partners
Andera Partners investment in Series C - ReViral
Perceptive Advisors
Perceptive Advisors investment in Series C - ReViral
CR-CP Life Science Fund
CR-CP Life Science Fund investment in Series C - ReViral
Green Sands Equity
Green Sands Equity investment in Series C - ReViral
OrbiMed
OrbiMed investment in Series C - ReViral
New Leaf Venture Partners
New Leaf Venture Partners investment in Series C - ReViral
Novo Holdings
Novo Holdings investment in Series C - ReViral
Brace Pharma
Brace Pharma investment in Series C - ReViral
OrbiMed
OrbiMed investment in Series B - ReViral
Novo Ventures
Novo Ventures investment in Series B - ReViral
Key Employee Changes
Date | New article |
---|---|
2022-01-17 | ReViral Appoints Brett Haumann as Chief Medical Officer |
Official Site Inspections
http://www.reviral.co.uk Semrush global rank: 2.15 M Semrush visits lastest month: 9.33 K
- Host name: 147.154.27.36
- IP address: 147.154.27.36
- Location: Seattle United States
- Latitude: 47.6109
- Longitude: -122.3303
- Metro Code: 819
- Timezone: America/Los_Angeles
- Postal: 98101